Wellcome is making £2 million available to the WHO and government of DRC to support vaccine research as part of the emergency response to the Ebola outbreak.
Developing new vaccines is challenging, costly and complex. CEPI is a new model for funding vaccine development which aims to change this.
Director of Innovation Stephen Caddick explains how his team has built its global portfolio to around £1 billion, touching the lives of more than 1.8 million people.
If we put research at the heart of epidemic response, it’s a double win – helping fight outbreaks that are underway and protecting us in the future.
Human infection studies have the power to rapidly accelerate the development of much-needed vaccines and treatments. Find out what they are, how they work and why they are important.
The global community showed the power of working together during the West African Ebola epidemic. Continuing to do so could be key to improving epidemic preparedness.
Three years on from an unprecedented epidemic in Central and South America, families affected by Zika are still benefiting from research studies supported since the outbreak began.
Lassa fever is now on the priority list of the World Health Organization and the Coalition for Epidemic Preparedness. But we need to continue to fill in the gaps in research.